Evidence map›Paper›PMID 25503558›Full record

ArticleCancer research2015

Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway.

David Van Mater, Leonor Añó, Jordan M Blum, Micah T Webster, WeiQiao Huang, Nerissa Williams, Yan Ma, Diana M Cardona, Chen-Ming Fan, David G Kirsch

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

David Van MaterDepartment of Pediatrics, Division of Hematology-Oncology, Duke University Medical Center, Durham, North Carolina.
Leonor AñóDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina.
Jordan M BlumDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina.
Micah T WebsterDepartment of Embryology, Carnegie Institution for Science, Baltimore, Maryland.
WeiQiao HuangDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Nerissa WilliamsDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Yan MaDepartment of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
Diana M CardonaDepartment of Pathology, Duke University Medical Center, Durham, North Carolina.
Chen-Ming FanDepartment of Embryology, Carnegie Institution for Science, Baltimore, Maryland.
David G KirschDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina. Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina. david.kirsch@duke.edu.
Duke Medical Center · USDuke University · USCarnegie Institution for Science · US

Funding

Center for Molecular &Cellular Studies of Ped DiseaseK12HD043494 · NICHD · DUKE UNIVERSITY · PI REED, ANN M. · 2003 to 2017
$5.2M
Muscle Stem Cell LineageR01AR060042 · NIAMS · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI FAN, CHEN-MING · 2010 to 2019
$3.5M
Mechanisms of Late Effects of Exposure to RadiationR01AI080488 · NIAID · DUKE UNIVERSITY · PI KIRSCH, DAVID GUY · 2008 to 2012
$2.1M
Radiation Therapy: Dissecting the Role of Stromal Cells in Tumor ControlR01CA169220 · NCI · DUKE UNIVERSITY · PI KIRSCH, DAVID GUY · 2013 to 2015
$1.3M
The role of cMET in satellite cells during muscle regenerationF32AR065366 · NIAMS · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI WEBSTER, MICAH TAUBE · 2013 to 2015
$152k
NCI NIH HHS R01 CA169220NCI NIH HHS R01CA169220NIAID NIH HHS R01 AI080488NIAMS NIH HHS F32 AR065366NIAMS NIH HHS F32AR065366NIAMS NIH HHS R01 AR060042NIAMS NIH HHS R01AR060042NICHD NIH HHS K12 HD043494NICHD NIH HHS K12HD043494
6 · The paper itself

Abstract

Some patients with soft-tissue sarcoma (STS) report a history of injury at the site of their tumor. Although this phenomenon is widely reported, there are relatively few experimental systems that have directly assessed the role of injury in sarcoma formation. We recently described a mouse model of STS whereby p53 is deleted and oncogenic Kras is activated in muscle satellite cells via a Pax7(CreER) driver following intraperitoneal injection with tamoxifen. Here, we report that after systemic injection of tamoxifen, the vast majority of Pax7-expressing cells remain quiescent despite mutation of p53 and Kras. The fate of these muscle progenitors is dramatically altered by tissue injury, which leads to faster kinetics of sarcoma formation. In adult muscle, quiescent satellite cells will transition into an active state in response to hepatocyte growth factor (HGF). We show that modulating satellite cell quiescence via intramuscular injection of HGF increases the penetrance of sarcoma formation at the site of injection, which is dependent on its cognate receptor c-MET. Unexpectedly, the tumor-promoting effect of tissue injury also requires c-Met. These results reveal a mechanism by which HGF/c-MET signaling promotes tumor formation after tissue injury in a mouse model of primary STS, and they may explain why some patients develop a STS at the site of injury.

Indexed as

AllelesAnimalsCardiotoxinsFemaleHepatocyte Growth FactorMiceMice, Inbred C57BLMuscle, SkeletalPAX7 Transcription FactorProto-Oncogene Proteins c-metras ProteinsSarcomaSignal TransductionSoft Tissue NeoplasmsTumor Suppressor Protein p53CardiotoxinsHepatocyte Growth FactorHGF protein, mousePax7 protein, mousePAX7 Transcription FactorProto-Oncogene Proteins c-metras ProteinsTumor Suppressor Protein p53

Identifiers

PMID25503558
PMCPMC4327867
OpenAlexW2116858468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.